Insider Transactions in Q3 2020 at Inozyme Pharma, Inc. (INZY)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 28
2020
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
375,000
+12.74%
|
$6,000,000
$16.0 P/Share
|
|
Jul 28
2020
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,194,379
+50.0%
|
-
|
|
Jul 28
2020
|
Sanofi > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
81,250
+13.51%
|
$1,300,000
$16.0 P/Share
|
|
Jul 28
2020
|
Sanofi > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
438,875
+50.0%
|
-
|
|
Jul 28
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
600,000
+23.04%
|
$9,600,000
$16.0 P/Share
|
|
Jul 28
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,403,653
+50.0%
|
-
|
|
Jul 28
2020
|
Rock Springs Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
600,000
+18.88%
|
$9,600,000
$16.0 P/Share
|
|
Jul 28
2020
|
Rock Springs Capital Management LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
467,884
+50.0%
|
-
|